Cargando…

Following the Omicron wave, the majority of children in England have evidence of previous COVID infection

Detalles Bibliográficos
Autores principales:	Oeser, C, Whitaker, H, Borrow, R, Linley, E, Tonge, S, Rowe, C, Otter, A, Warrener, L, Campbell, CNJ, Ladhani, S, Ramsay, M, Brown, KE, Amirthalingam, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759455/ https://www.ncbi.nlm.nih.gov/pubmed/36543312 http://dx.doi.org/10.1016/j.jinf.2022.12.012

Ejemplares similares

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
por: Whitaker, Heather J, et al.
Publicado: (2021)

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
por: Westrop, Samantha J, et al.
Publicado: (2022)

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
por: Aiano, Felicity, et al.
Publicado: (2023)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network
por: Whitaker, Heather, et al.
Publicado: (2022)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Lessons learnt from the implementation of maternal immunization programs in England
por: Amirthalingam, G., et al.
Publicado: (2016)

Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study
por: Simmons, Ruth D., et al.
Publicado: (2015)

Vaccination plus previous infection: protection during the omicron wave in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
por: Ladhani, Shamez N., et al.
Publicado: (2016)

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England
por: Powell, Annabel A, et al.
Publicado: (2021)

Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
por: Ladhani, Shamez N., et al.
Publicado: (2012)

COVID-19 vaccine given to children with comorbidities in England, December 2020–June 2021
por: Aiano, Felicity, et al.
Publicado: (2022)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
por: Ladhani, Shamez N, et al.
Publicado: (2021)

Comparison of COVID-19 pneumonia during the SARS-CoV-2 Omicron wave and the previous non-Omicron wave in a single facility
por: Ito, Noriaki, et al.
Publicado: (2022)

Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
por: Ireland, Georgina, et al.
Publicado: (2021)

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
por: Powell, Annabel A, et al.
Publicado: (2023)

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
por: Oligbu, Godwin, et al.
Publicado: (2019)

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
por: Amirthalingam, Gayatri, et al.
Publicado: (2016)

Trends in laboratory-confirmed bacterial meningitis (2012–2019): national observational study, England
por: Subbarao, Sathyavani, et al.
Publicado: (2023)

SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England
por: Sinnathamby, Mary A, et al.
Publicado: (2020)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales
por: Andrews, Nick, et al.
Publicado: (2011)

Outbreak strain characterisation and pharyngeal carriage detection following a protracted group B meningococcal outbreak in adolescents in South-West England
por: Clark, Stephen A., et al.
Publicado: (2019)

Understanding the immunological landscape of England during SARS-CoV2 Omicron variant wave
por: Shingleton, Joseph, et al.
Publicado: (2022)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
por: Tessier, Elise, et al.
Publicado: (2020)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
por: Makwana, Ashley, et al.
Publicado: (2018)

Accelerating Control of Pertussis in England and Wales
por: Campbell, Helen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0q2nfak06khi6sfgmq4o8o4vme